Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis

about

Pharmacokinetic Variability of Daptomycin during Prolonged Therapy for Bone and Joint Infections.Daptomycin dosing strategies in patients receiving thrice-weekly intermittent hemodialysis.Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients.

P2860

Q36888137-1B3338B9-9385-4307-A72B-2E973125B016 Q38164685-19C76862-C558-4D78-AB0A-306B6F072A94 Q38895642-572878E2-ADBC-4983-A27B-9FC2184C018A

P2860

Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis

Item

http://www.wikidata.org/entity/Q36558512

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Daptomycin pharmacokinetics an ...... ing thrice-weekly hemodialysis

@ast

Daptomycin pharmacokinetics an ...... ing thrice-weekly hemodialysis

@en

type

Item

label

Daptomycin pharmacokinetics an ...... ing thrice-weekly hemodialysis

@ast

Daptomycin pharmacokinetics an ...... ing thrice-weekly hemodialysis

@en

prefLabel

Daptomycin pharmacokinetics an ...... ing thrice-weekly hemodialysis

@ast

Daptomycin pharmacokinetics an ...... ing thrice-weekly hemodialysis

@en

P1476

Daptomycin pharmacokinetics an ...... ing thrice-weekly hemodialysis

@en

P2093

Bruce A Mueller

http://www.w3.org/2001/XMLSchema#string

Darren W Grabe

http://www.w3.org/2001/XMLSchema#string

Jill M Butterfield

http://www.w3.org/2001/XMLSchema#string

Katie E Cardone

http://www.w3.org/2001/XMLSchema#string

Nimish Patel

http://www.w3.org/2001/XMLSchema#string

Noha N Salama

http://www.w3.org/2001/XMLSchema#string

Thomas P Lodise

http://www.w3.org/2001/XMLSchema#string

P2860

Anthropometric reference data for children and adults: United States, 2003–2006.

Single-dose daptomycin pharmacokinetics in chronic haemodialysis patients.

Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis.

Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis.

In vivo pharmacodynamic activity of daptomycin

Dialysis catheter-related bacteremia: treatment and prophylaxis.

Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis.

Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.

P304

864-872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02000-12

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23208714

http://www.w3.org/2001/XMLSchema#string

P932

3553729

http://www.w3.org/2001/XMLSchema#string

Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis

about

P2860

P2860

Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932